# ECT/Succinylcholine: Biochemical, Serum and Cardiovascular Changes

> **NCT00750906** · — · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 13 (actual)

## Conditions studied

- Depression

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00750906
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** 2015-04-30
- **Final completion:** 2015-04-30
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Study on hold since 2009. Awaiting FDA approval of Sugammdex to complete second arm of study.
- **Last updated:** 2020-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00750906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00750906, "ECT/Succinylcholine: Biochemical, Serum and Cardiovascular Changes". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00750906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*